11341 related articles for article (PubMed ID: 10513635)
1. Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion.
Kagechika H; Komoda M; Fujimoto Y; Koiso Y; Takayama H; Kadoya S; Miyata K; Kato F; Kato M; Hashimoto Y
Biol Pharm Bull; 1999 Sep; 22(9):1010-2. PubMed ID: 10513635
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of novel specific aminopeptidase inhibitors with a cyclic imide skeleton].
Takahashi H; Komoda M; Kakuta H; Hashimoto Y
Yakugaku Zasshi; 2000 Oct; 120(10):909-21. PubMed ID: 11082703
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibitor of puromycin-sensitive aminopeptidase with a homophthalimide skeleton: identification of the target molecule and a structure-activity relationship study.
Komoda M; Kakuta H; Takahashi H; Fujimoto Y; Kadoya S; Kato F; Hashimoto Y
Bioorg Med Chem; 2001 Jan; 9(1):121-31. PubMed ID: 11197332
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines.
Sekine K; Fujii H; Abe F; Nishikawa K
Int J Cancer; 2001 Nov; 94(4):485-91. PubMed ID: 11745433
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors.
Fujii H; Nakajima M; Aoyagi T; Tsuruo T
Biol Pharm Bull; 1996 Jan; 19(1):6-10. PubMed ID: 8820902
[TBL] [Abstract][Full Text] [Related]
6. Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions.
Grujić M; Renko M
Cancer Lett; 2002 Aug; 182(2):113-9. PubMed ID: 12048155
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I
Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304
[TBL] [Abstract][Full Text] [Related]
8. Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeleton.
Kakuta H; Tanatani A; Nagasawa K; Hashimoto Y
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1273-82. PubMed ID: 14600372
[TBL] [Abstract][Full Text] [Related]
9. CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.
Krige D; Needham LA; Bawden LJ; Flores N; Farmer H; Miles LE; Stone E; Callaghan J; Chandler S; Clark VL; Kirwin-Jones P; Legris V; Owen J; Patel T; Wood S; Box G; Laber D; Odedra R; Wright A; Wood LM; Eccles SA; Bone EA; Ayscough A; Drummond AH
Cancer Res; 2008 Aug; 68(16):6669-79. PubMed ID: 18701491
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin).
Yoneda J; Saiki I; Fujii H; Abe F; Kojima Y; Azuma I
Clin Exp Metastasis; 1992 Jan; 10(1):49-59. PubMed ID: 1733647
[TBL] [Abstract][Full Text] [Related]
11. A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
Saitoh Y; Koizumi K; Minami T; Sekine K; Sakurai H; Saiki I
Biol Pharm Bull; 2006 Apr; 29(4):709-12. PubMed ID: 16595904
[TBL] [Abstract][Full Text] [Related]
12. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
[TBL] [Abstract][Full Text] [Related]
13. Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.
Shimazawa R; Takayama H; Fujimoto Y; Komoda M; Dodo K; Yamasaki R; Shirai R; Koiso Y; Miyata K; Kato F; Kato M; Miyachi H; Hashimoto Y
J Enzyme Inhib; 1999; 14(4):259-75. PubMed ID: 10445048
[TBL] [Abstract][Full Text] [Related]
14. Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways.
Sawafuji K; Miyakawa Y; Weisberg E; Griffin JD; Ikeda Y; Kizaki M
Leuk Lymphoma; 2003 Nov; 44(11):1987-96. PubMed ID: 14738154
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M
J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022
[TBL] [Abstract][Full Text] [Related]
16. Progress in the development of bestatin analogues as aminopeptidases inhibitors.
Chen L; Teng Y; Xu W
Curr Med Chem; 2011; 18(7):964-76. PubMed ID: 21254977
[TBL] [Abstract][Full Text] [Related]
17. Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.
Baxter AD; Bhogal R; Bird J; Keily JF; Manallack DT; Montana JG; Owen DA; Pitt WR; Watson RJ; Wills RE
Bioorg Med Chem Lett; 2001 Jun; 11(11):1465-8. PubMed ID: 11378378
[TBL] [Abstract][Full Text] [Related]
18. alpha-Keto amide inhibitors of aminopeptidases.
Ocain TD; Rich DH
J Med Chem; 1992 Feb; 35(3):451-6. PubMed ID: 1738140
[TBL] [Abstract][Full Text] [Related]
19. Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix.
van Hensbergen Y; Broxterman HJ; Peters E; Rana S; Elderkamp YW; van Hinsbergh VW; Koolwijk P
Thromb Haemost; 2003 Nov; 90(5):921-9. PubMed ID: 14597989
[TBL] [Abstract][Full Text] [Related]
20. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR
Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
